Sanofi Pasteur pediatric H1N1 vaccine recall: No danger and no need of an extra dose

There is no danger if your child received the H1N1 vaccine that was recalled by Sanofi Pasteur. That is the information being provided to anyone calling the NJ Poison Control Center's hotline, according to Bruce Ruck, Pharm.D., Director of Drug Information and Professional Education. The public should be reassured that this recall took place because specific lots were found to be slightly weaker than they should have been. The vaccine involved was intended for use only in children 6 months to 35 months of age and was in prefilled syringes. If a child was outside of that age group or did not get the vaccine in a prefilled syringe, this recall does not apply at all. Further, according to the Centers for Disease Control and Prevention (CDC), the potency of the vaccine was still good enough to provide immunity for the children who received the vaccine, provided the second dose is received 28 days later.

According to Peter Wenger, MD, a Pediatric Infectious Disease Specialist at UMDNJ-New Jersey Medical School, there are no safety concerns related to this recall. Based upon the information received from the CDC, Dr. Wenger said he expects the vaccine to be effective. Revaccination is not being suggested at this time. All children under the age of 10 should always receive a second dose of vaccine, regardless of what vaccine they received. No one needs an extra dose because of the recall.

For more information, visit www.njpies.org or call the center's hotline at 1-800-222-1222.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Cleveland Clinic presents new findings on triple-negative breast cancer vaccine